Hira, S Kumar <br/><br/>
Combined immunotherapy with whole tumor lysate-pulsed interleukin-15-activated dendritic cells and cucurbitacin I promotes strong CD8(+) T-cell responses and cures highly aggressive lymphoma.  [electronic resource] 

 -  Cytotherapy  May 2015 
 - 647-64 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-2566 
<br/><br/><label>Standard No.: </label>10.1016/j.jcyt.2015.01.006  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antioxidants--metabolism<br/>Blood Glucose--metabolism<br/>CD4-Positive T-Lymphocytes--drug effects<br/>CD8-Positive T-Lymphocytes--drug effects<br/>Cell Extracts--therapeutic use<br/>Cell Proliferation--drug effects<br/>Cytokines--metabolism<br/>Cytotoxicity, Immunologic--drug effects<br/>Dendritic Cells--drug effects<br/>Immunotherapy<br/>Interleukin-15--pharmacology<br/>Lymphoma--immunology<br/>Mice, Inbred AKR<br/>Neoplasm Metastasis<br/>Organ Specificity--drug effects<br/>Remission Induction<br/>Survival Analysis<br/>TNF-Related Apoptosis-Inducing Ligand--metabolism<br/>Triterpenes--pharmacology<br/>Tumor Necrosis Factor-alpha--metabolism<br/>Vaccination